Novanta Inc. (NOVT)

Market Cap	5.62B +31.8%
Revenue (ttm)	1.00B +5.6%
Net Income	53.72M -23.9%
EPS	1.41 -27.6%
Shares Out	35.61M
PE Ratio	111.84
Forward PE	42.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	245,862
Open	161.61
Previous Close	159.19
Day's Range	156.57 - 165.56
52-Week Range	98.27 - 165.56
Beta	1.62
Analysts	Buy
Price Target	173.00 (+9.69%)
Earnings Date	May 11, 2026

About NOVT

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: NOVT
• Website: https://www.novanta.com

Financial Performance

In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.

Analyst Summary

According to one analyst, the rating for NOVT stock is "Buy" and the 12-month stock price target is $173.0.

Price Target

$173.0

(9.69% upside)

Analyst Consensus: Buy